What is TISSOMICS™?
TISSOMICS™ is a drug discovery and development approach combining genomics and proteomics with histological, pathological and clinical data derived from normal and diseased tissue.
“Clinical Trial on a Chip”
By combining TISSOMICS™ with tissue microarray (TMA) technology, entire patient cohorts can be analyzed for multiple targets and biomarkers in a high-throughput format.
For more information on TISSOMICS™ and its application in validation of drug targets and biomarkers, please contact us .
TISSOMICS™ is a registered trademark of ORIDIS Biomarkers